Background reading on the compounds we carry. All references link to primary literature.
BPC-157 (Body Protection Compound) is a pentadecapeptide derived from human gastric juice. Research has examined its role in accelerating soft tissue healing, protecting gastric mucosa, and modulating the dopaminergic system. Studies in rodent models demonstrate consistent efficacy in tendon and ligament repair models.
Browse PubMed literature āThymosin Beta-4 fragment (TB-500) is a synthetic version of the naturally occurring TĪ²4 protein. It promotes angiogenesis and cell migration. Preclinical studies have investigated its potential in myocardial infarction recovery, corneal healing, and dermal wound repair.
Browse PubMed literature āSemaglutide and tirzepatide represent the leading edge of GLP-1 and dual GIP/GLP-1 agonist research. Active investigation spans type 2 diabetes management, obesity, non-alcoholic fatty liver disease, and cardiovascular risk reduction in high-risk populations.
Browse PubMed literature āAll research summaries are provided for informational purposes only. RGV PRIME Research Lab does not endorse any specific research application. All compounds are sold strictly for in vitro and laboratory research use. Not for human consumption.
Our products are research compounds intended for use by qualified adults 21 years of age or older. You must confirm your age to proceed.
By entering this site you confirm you are 21+ and agree to our terms of use. All products are for laboratory research use only and not for human consumption.
You must be 21 or older to access this site. Please come back when you meet the age requirement.